The Effects of Diabetes and Glycemic Control on Cancer Outcomes in Individuals With Metastatic Breast Cancer.
Yee-Ming Melody CheungMelissa HughesJulia HarrodJanet FilesGreg KirknerLauren BuckleyNancy U LinSara M TolaneyMarie E McDonnellLe MinPublished in: The Journal of clinical endocrinology and metabolism (2022)
Diabetes was not associated with increased mortality in individuals with MBC at 5 years. However, diabetes and hyperglycemia were associated with worse OS among a cohort of longer-term survivors. These findings suggest that individualized diabetes and glycemic goals should be considered in patients with MBC.